News
🌏 NMPALatest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 1–12 of 259 articles
Quick answer
NovaPharmaNews Asia-Pacific Region news feed tracks 259 published stories — NMPA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
NMPA Accepts Everest LEROCHOL PCSK9 BLA
NMPA Clears Kelun-Harbour Asthma Bispecific IND
Neuronata-R Keeps Korea ALS Conditional Nod
Orasis Files BESKA Presbyopia NDA in Australia
Hansoh Ris-Rez Hits OS Goal in China SCLC Trial
Orzeyful: NMPA Clears First OX2R Agonist for NT1
Telix Completes Illuccix Japan Phase 3 Enrollment
NMPA Accepts Toripalimab Perioperative NSCLC sNDA
NMPA Approves Iza-bren for ESCC in China
Takeda TAK-003 Wins India Dengue Vaccine Nod
NMPA Approves Ciprocopan for PNH in China
Clinical trials market to $176B; APAC DCT rise
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.